Protective effect of UR-12670 on chronic nephropathy induced by warm ischaemia in ageing uninephrectomized rats

Nephrology Dialysis Transplantation

Volumn 16, Issue 4, 2001, Pages 735-741

  Lloberas, Núria ^a   Cruzado, Josep M ^a   Torras, Joan ^a   Herrero Fresneda, Immaculada ^a   Riera, Marta ^a   Merlos, Manel ^b   Grinyó, Josep M ^a,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Grup Uriach   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Ageing; Chronic nephropathy; PAF; PAF receptor antagonist; Tubulo interstitial damage; Warm ischaemia

Indexed keywords

1 [[1 (3,3 DIPHENYLPROPANOYL) 4 PIPERIDYL]METHYL] 1 H 2 METHYLIMIDAZO [4,5 C] PYRIDINE; ATROPINE; DIAZEPAM; GINKGOLIDE B; KETAMINE; MONOCLONAL ANTIBODY; PHOSPHOLIPID; PYRIDINE DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG; UR 12670;

ACUTE KIDNEY FAILURE; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG EFFECT; EXPOSURE; FOLLOW UP; GLOMERULOSCLEROSIS; GRAFT REJECTION; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY INTERSTITIUM; KIDNEY ISCHEMIA; KIDNEY MASS; KIDNEY TUBULE; MACROPHAGE; MALE; MONITORING; MONOCYTE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEINURIA; RAT; REPERFUSION INJURY; UNINEPHRECTOMY;

EID: 0035084764     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.4.735     Document Type: Article

References (32)

1. Renal transplantation in recipients over the age of 60. The impact of donor age
2. Renal transplantation with limit donors: To what should the good results obtained be attributed
3. The aging kidney: Insights from experimental studies
4. The aging kidney
5. Aging and the kidney
6. Tubulointerstitial disease in aging: Evidence for underlying peritubular capillary damage, a potential role for renal ischemia
7. Reactive oxygen species and platelet-activating factor synthesis in age-related glomerulosclerosis
8. Age-related increase in expression of TGF-β1 in the rat kidney: Relationship to morphologic changes
9. Platelet-activating factor: A mediator for clinicians
10. Protective effect of the PAF antagonist, BN 52021, in an experimental renal warm ischemia model
11. Neutrophils accentuate renal cold ischemia-reperfusion injury. Role of PAF and beneficial effect of a PAF antagonist
12. BN 52021: A platelet activating factor antagonist for preventing post-transplant renal failure
13. Long-term protective effect of UR-12670 after renal warm ischemia in uninephrectomized rats
14. Platelet activating factor stimulates gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: Role of TGF-β1
15. Overexpression of extracellular matrix proteins in renal tubulointerstitial cells by platelet activating factor stimulation
16. Early experience with dual kidney transplantation in adults using expanded donor criteria
17. Influence of nephron mass in development of chronic renal failure after prolonged warm renal ischemia
18. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2-methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists
19. Effects of a new antagonist of platelet-activating factor, UR-12670, on several endotoxic shock markers in rats
20. Stereological methods
21. Renal Protective effect of liposomed superoxide dismutase in an experimental warm ischemic model
22. Protective effect of exogenous nitric oxide on the renal function and inflammatory response in a model of ischemia-reperfusion
23. Age-dependent differences in the effect of ischemia on the rat kidney: Prevention of the postischemic damage by different drugs
24. Functional versus structural changes in the pathophysiology of acute ischemic renal failure in aging rats
25. Increased PMN adherence on endothelial cells after hypoxia: Involvement of PAF, CD18/ CD11b and ICAM-1
26. Prevention of functional, structural and molecular changes of chronic rejection of rat renal allografts by a specific macrophage inhibitor
27. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells
28. Interstitial mononuclear cell infiltrates in experimental nephrosis: Effect of PAF antagonist
29. Expression of the PAF receptor in human monocyte-derived macrophages is downregulated by oxidized LDL. Relevance to the inflammatory phase of atherogenesis
30. Platelet activating factor alters glomerular barrier size selectivity for macromolecules in rats
31. The role of platelet activating factor (PAF) in experimental glomerular injury
32. Reactive oxygen species and platelet-activating factor synthesis in age-related glomerulosclerosis